Skip to main content

Advertisement

SpringerLink
Log in

High expression level of TMPRSS4 predicts adverse outcomes of colorectal cancer patients

  • Original Paper
  • Published:
Medical Oncology Aims and scope Submit manuscript

Abstracts

Transmembrane protease/serine 4 (TMPRSS4), a member of the type II transmembrane serine protease family, is highly expressed in some human cancers and involved in the EMT regulation of cancer cells. The prognostic value of TMPRSS4 in colorectal cancer (CRC) has not been discussed. This study aims to evaluate the association between TMPRSS4 expressions and survival in CRC patients. Immunohistochemistry revealed high expression of TMPRSS4 in 69/122 CRC samples, compared with 14/47 in normal tissues (P < 0.01). Correlation analysis showed high expression of TMPRSS4 was significantly associated with advanced TNM stage (P = 0.011), pT (P = 0.019), pN (P = 0.035), and pM status (P = 0.004). Higher TMPRSS4 predicted shorter overall survival (OS) and disease-free survival (DFS) in CRC patients (P < 0.01, both). Moreover, both TMPRSS4 expression and TNM stage were independent predictive factors of OS and DFS in Cox regression analysis. The findings in our study demonstrated the potential value of TMPRSS4 expression level as a prognostic biomarker for CRC patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Choi SY, Bertram S, Glowacka I, Park YW, Pohlmann S. Type II transmembrane serine proteases in cancer and viral infections. Trends Mol Med. 2009;15(7):303–12.

    Article  CAS  PubMed  Google Scholar 

  2. Szabo R, Bugge TH. Type II transmembrane serine proteases in development and disease. Int J Biochem Cell Biol. 2008;40(6–7):1297–316.

    Article  CAS  PubMed  Google Scholar 

  3. Wallrapp C, Hahnel S, Muller-Pillasch F, Burghardt B, Iwamura T, Ruthenburger M, et al. A novel transmembrane serine protease (TMPRSS3) overexpressed in pancreatic cancer. Cancer Res. 2000;60(10):2602–6.

    CAS  PubMed  Google Scholar 

  4. Larzabal L, Nguewa PA, Pio R, Blanco D, Sanchez B, Rodriguez MJ, et al. Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology. Br J Cancer. 2011;105(10):1608–14.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Nguyen TH, Weber W, Havari E, Connors T, Bagley RG, McLaren R, et al. Expression of TMPRSS4 in non-small cell lung cancer and its modulation by hypoxia. Int J Oncol. 2012;41(3):829–38.

    PubMed Central  CAS  PubMed  Google Scholar 

  6. Jarzab B, Wiench M, Fujarewicz K, Simek K, Jarzab M, Oczko-Wojciechowska M, et al. Gene expression profile of papillary thyroid cancer sources of variability and diagnostic implications. Cancer Res. 2005;65(4):1587–97.

    Article  CAS  PubMed  Google Scholar 

  7. Kebebew E, Peng M, Reiff E, Duh Q-Y, Clark OH, McMillan A. ECM1 and TMPRSS4 are diagnostic markers of malignant thyroid neoplasms and improve the accuracy of fine needle aspiration biopsy. Trans Meet Am Surg Assoc. 2005;123:57–66.

    Google Scholar 

  8. Kebebew E, Peng M, Reiff E, McMillan A. Diagnostic and extent of disease multigene assay for malignant thyroid neoplasms. Cancer. 2006;106(12):2592–7.

    Article  PubMed  Google Scholar 

  9. Cheng D, Kong H, Li Y. TMPRSS4 as a poor prognostic factor for triple-negative breast cancer. Int J Mol Sci. 2013;14(7):14659–68.

    Article  PubMed Central  PubMed  Google Scholar 

  10. Liang B, Wu M, Bu Y, Zhao A, Xie F. Prognostic value of TMPRSS4 expression in patients with breast cancer. Med Oncol. 2013;30(2):497.

    Article  PubMed  Google Scholar 

  11. Kim S, Kang HY, Nam EH, Choi MS, Zhao XF, Hong CS, et al. TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin alpha5 and its signaling pathways. Carcinogenesis. 2010;31(4):597–606.

    Article  CAS  PubMed  Google Scholar 

  12. Jung H, Lee KP, Park SJ, Park JH, Jang YS, Choi SY, et al. TMPRSS4 promotes invasion, migration and metastasis of human tumor cells by facilitating an epithelial-mesenchymal transition. Oncogene. 2008;27(18):2635–47.

    Article  CAS  PubMed  Google Scholar 

  13. Cheng H, Fukushima T, Takahashi N, Tanaka H, Kataoka H. Hepatocyte growth factor activator inhibitor type 1 regulates epithelial to mesenchymal transition through membrane-bound serine proteinases. Cancer Res. 2009;69(5):1828–35.

    Article  CAS  PubMed  Google Scholar 

  14. Jia JB, Wang WQ, Sun HC, Liu L, Zhu XD, Kong LQ, et al. A novel tripeptide, tyroserleutide, inhibits irradiation-induced invasiveness and metastasis of hepatocellular carcinoma in nude mice. Invest New Drugs. 2011;29(5):861–72.

    Article  CAS  PubMed  Google Scholar 

  15. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin. 2013;63(1):11–30.

    Article  PubMed  Google Scholar 

  16. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69–90.

    Article  PubMed  Google Scholar 

  17. Bolocan A, Ion D, Ciocan DN, Paduraru DN. Prognostic and predictive factors in colorectal cancer. Chirurgia (Bucur). 2012;107(5):555–63.

    CAS  PubMed  Google Scholar 

  18. Kalluri R, Weinberg RA. The basics of epithelial-mesenchymal transition. J Clin Invest. 2009;119(6):1420–8.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  19. Zeisberg M, Neilson EG. Biomarkers for epithelial-mesenchymal transitions. J Clin Invest. 2009;119(6):1429–37.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Tiwari N, Gheldof A, Tatari M, Christofori G. EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol. 2012;22(3):194–207.

    Article  CAS  PubMed  Google Scholar 

  21. Scheel C, Weinberg RA. Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links. Semin Cancer Biol. 2012;22(5–6):396–403.

    Article  CAS  PubMed  Google Scholar 

  22. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell. 2008;133(4):704–15.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  23. Guo W, Keckesova Z, Donaher JL, Shibue T, Tischler V, Reinhardt F, et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell. 2012;148(5):1015–28.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  24. Sampieri K, Fodde R. Cancer stem cells and metastasis. Semin Cancer Biol. 2012;22(3):187–93.

    Article  CAS  PubMed  Google Scholar 

  25. Zhu Q-C, Gao R-Y, Wu W, Qin H-L. Epithelial-mesenchymal transition and its role in the pathogenesis of colorectal cancer. Asian Pac J Cancer Prev. 2013;14(5):2689–98.

    Article  PubMed  Google Scholar 

  26. Ohler A, Becker-Pauly C. Morpholino knockdown of the ubiquitously expressed transmembrane serine protease TMPRSS4a in zebrafish embryos exhibits severe defects in organogenesis and cell adhesion. Biol Chem. 2011;392(7):653–64.

    Article  CAS  PubMed  Google Scholar 

  27. Choi SY, Shin HC, Kim SY, Park YW. Role of TMPRSS4 during cancer progression. Drug News Perspect. 2008;21(8):417–23.

    CAS  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Department of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197, Ruijin 2nd Road, Shanghai, 200025, People’s Republic of China

    Ao Huang, Hongchao Zhao, Yingjun Quan, Bo Feng & Minhua Zheng

  2. Shanghai Institute of Digestive Surgery, Shanghai, People’s Republic of China

    Ao Huang, Hongchao Zhao, Yingjun Quan, Bo Feng & Minhua Zheng

  3. Shanghai Minimally Invasive Surgery Center, Shanghai, People’s Republic of China

    Ao Huang, Hongchao Zhao, Yingjun Quan, Bo Feng & Minhua Zheng

  4. Department of General Surgery, Qingdao Municipal Hospital, No. 5, Donghai Middle Road, Shandong, People’s Republic of China

    Houmin Zhou

Authors
  1. Ao Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Houmin Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hongchao Zhao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yingjun Quan
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Bo Feng
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Minhua Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Minhua Zheng.

Additional information

Houmin Zhou is a co-first author

Rights and permissions

Reprints and permissions

About this article

Cite this article

Huang, A., Zhou, H., Zhao, H. et al. High expression level of TMPRSS4 predicts adverse outcomes of colorectal cancer patients. Med Oncol 30, 712 (2013). https://doi.org/10.1007/s12032-013-0712-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12032-013-0712-7

Keywords

Search

Navigation